| Literature DB >> 27237592 |
Felipe Villar Álvarez1, Ignacio Muguruza Trueba2, José Belda Sanchis3, Laureano Molins López-Rodó4, Pedro Miguel Rodríguez Suárez5, Julio Sánchez de Cos Escuín6, Esther Barreiro7, M Henar Borrego Pintado8, Carlos Disdier Vicente9, Javier Flandes Aldeyturriaga10, Pablo Gámez García11, Pilar Garrido López12, Pablo León Atance13, José Miguel Izquierdo Elena14, Nuria M Novoa Valentín15, Juan José Rivas de Andrés16, Íñigo Royo Crespo16, Ángel Salvatierra Velázquez17, Luís M Seijo Maceiras18, Segismundo Solano Reina19, David Aguiar Bujanda20, Régulo J Avila Martínez11, Jose Ignacio de Granda Orive21, Eva de Higes Martinez22, Vicente Diaz-Hellín Gude11, Raúl Embún Flor16, Jorge L Freixinet Gilart5, María Dolores García Jiménez13, Fátima Hermoso Alarza11, Samuel Hernández Sarmiento20, Antonio Francisco Honguero Martínez13, Carlos A Jimenez Ruiz23, Iker López Sanz14, Andrea Mariscal de Alba11, Primitivo Martínez Vallina16, Patricia Menal Muñoz24, Laura Mezquita Pérez12, María Eugenia Olmedo García12, Carlos A Rombolá13, Iñigo San Miguel Arregui25, María de Valle Somiedo Gutiérrez10, Ana Isabel Triviño Ramírez13, Joan Carles Trujillo Reyes3, Carmen Vallejo26, Paz Vaquero Lozano19, Gonzalo Varela Simó15, Javier J Zulueta27.
Abstract
The Thoracic Surgery and Thoracic Oncology groups of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) have backed the publication of a handbook on recommendations for the diagnosis and treatment of non-small cell lung cancer. Due to the high incidence and mortality of this disease, the best scientific evidence must be constantly updated and made available for consultation by healthcare professionals. To draw up these recommendations, we called on a wide-ranging group of experts from the different specialties, who have prepared a comprehensive review, divided into 4 main sections. The first addresses disease prevention and screening, including risk factors, the role of smoking cessation, and screening programs for early diagnosis. The second section analyzes clinical presentation, imaging studies, and surgical risk, including cardiological risk and the evaluation of respiratory function. The third section addresses cytohistological confirmation and staging studies, and scrutinizes the TNM and histological classifications, non-invasive and minimally invasive sampling methods, and surgical techniques for diagnosis and staging. The fourth and final section looks at different therapeutic aspects, such as the role of surgery, chemotherapy, radiation therapy, a multidisciplinary approach according to disease stage, and other specifically targeted treatments, concluding with recommendations on the follow-up of lung cancer patients and surgical and endoscopic palliative interventions in advanced stages.Entities:
Keywords: Cáncer de pulmón; Diagnosis; Diagnóstico; Lung cancer; Recomendaciones; Recommendations; Tratamiento; Treatment
Mesh:
Substances:
Year: 2016 PMID: 27237592 DOI: 10.1016/j.arbres.2016.02.016
Source DB: PubMed Journal: Arch Bronconeumol ISSN: 0300-2896 Impact factor: 4.872